What it's actually good for
Phosphatidylserine (PS) is a phospholipid concentrated in cell membranes, especially in the brain, where it's involved in neurotransmitter release and synaptic signaling. Two separate research threads support it, and they don't overlap much. One is cognitive: in older adults with existing memory complaints or age-related decline, PS at 100-300 mg/day has a real, if modest, track record. The other is hormonal: at higher doses, PS blunts the cortisol spike triggered by intense exercise. Neither line of evidence says much about whether a healthy 30-year-old will think faster on PS — that's the gap between "this compound does something measurable" and "this compound will help you specifically."
What the research says
Cognitive function in older adults (Grade B). The largest and most-cited trial here is Cenacchi et al. (1993), a double-blind, placebo-controlled study of 494 elderly patients (65-93) with moderate-to-severe cognitive decline, given 300 mg/day of PS for 6 months. It found statistically significant improvements over placebo on standard geriatric cognitive and behavioral scales, with no safety signal. On the strength of this kind of data, the FDA in 2003 allowed a qualified health claim linking PS to reduced risk of cognitive dysfunction and dementia in the elderly — but the agency's own required disclaimer says the supporting research is "very limited and preliminary" and that there is "little scientific evidence" behind it. That's the honest headline: real signal in a narrow population (older adults with existing decline), not a demonstrated brain boost for healthy younger people looking for an edge.
Cortisol modulation after exercise (Grade B). Starks et al. (2008) ran a small crossover trial — 10 healthy men, 600 mg/day of PS for 10 days — and found significantly lower peak cortisol and cortisol area-under-curve after a moderate-intensity cycling protocol, plus a better testosterone-to-cortisol ratio, compared to placebo. Lactate and growth hormone didn't move. It's a real, statistically clean result, but it's one small trial with 10 subjects — enough to establish plausibility, not enough to call it settled. Other trials in this space have generally needed doses above 400 mg/day to see a consistent cortisol effect; below that, results are inconsistent.
How much, and which form
100-300 mg/day is the range with cognitive-support evidence behind it, typically split across meals. 400-800 mg/day is what the cortisol-modulation trials used — Starks used 600 mg/day. Modern supplements use soy- or sunflower-derived PS; the original studies (including Cenacchi's) used bovine cortex-derived PS, pulled from the market after BSE ("mad cow") concerns in the 1990s. Plant-derived PS is generally assumed to be bioequivalent, but that assumption rests on less direct trial data than the original bovine-derived studies.
Safety & interactions
PS has been well tolerated up to 600 mg/day in trials running as long as 6 months, with occasional mild GI upset or insomnia at higher doses. Soy-derived forms are an obvious concern for soy-allergic users — choose sunflower-derived PS instead. There's a theoretical interaction with blood thinners and anticholinergic drugs, and a theoretical (not established) interaction with anything else that affects cortisol. This is informational, not medical advice — check with a clinician before starting, especially if pregnant, nursing, on medication, or managing a chronic condition.
How we picked the brand
A PS product earns a spot when it clearly states elemental PS content (not just "phosphatidylserine complex"), discloses the source (soy or sunflower), skips proprietary blends, and comes from a GMP-certified manufacturer with independent testing behind it.